Nalaganje...
Pharmacokinetics of liposomal amphotericin B (Ambisome) in critically ill patients.
The liposomal formulation of amphotericin B (AmBisome) greatly reduces the acute and chronic side effects of the parent drug. The present study describes the pharmacokinetic characteristics of AmBisome applied to 10 patients at a dose of 2.8 to 3.0 mg/kg of body weight and compares them to the pharm...
Shranjeno v:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | en |
| Izdano: |
1997
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC163899/ https://ncbi.nlm.nih.gov/pubmed/9174183 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|